Han Lei, Zhang Yan, Zhang Yonghui, Wu Wei, He Ping
Medical and Education Department, Southwest Hospital, the First Hospital Affiliated to Army Medical University, Chongqing 400038, China.
Critical Care Medicine, Southwest Hospital, the First Hospital Affiliated to Army Medical University, Chongqing 400038, China.
Ann Transl Med. 2019 Sep;7(18):476. doi: 10.21037/atm.2019.08.07.
Refractory septic shock is a serious disorder with high mortality. There is currently limited evidence to support the use of extracorporeal membrane oxygenation (ECMO) in adult septic shock. We describe the outcome of patients with refractory septic shock in our hospital and try to identify prognostic factors.
We studied a total of 23 (14 males and 9 females) refractory septic shock patients treated with venoarterial (VA) ECMO in our hospital. Clinical parameters of survival and death groups, laboratory parameters before and after ECMO placement were analyzed.
Eight patients were successfully weaned off ECMO and five patients were discharged. The sepsis-related organ failure assessment (SOFA) score and shock-to-ECMO interval before ECMO placement in the survival group were significantly lower than those in the death group (12.0 15.0, P=0.007; 23.5 42.2 h, P=0.037). The number of cases who had the normal range of ScvO% between the survival group and the death group at 12 h (4 4, P=0.033), 18 h (5 7, P=0.016) and 24 h (5 9, P=0.043) during ECMO was significantly different. In univariate logistic regression analysis, the case of patients with normal central venous oxygen saturation (ScvO) % at 12 h during ECMO [odds ratio (OR) 14.0, 95% confidence interval (CI): 1.200-163.367, P=0.035] was significantly associated with risk of the prognosis of patients.
In adult refractory septic shock patients, ScvO% at 12 h during ECMO may be a risk factor for patient prognosis.
难治性感染性休克是一种死亡率很高的严重疾病。目前,支持在成人感染性休克中使用体外膜肺氧合(ECMO)的证据有限。我们描述了我院难治性感染性休克患者的治疗结果,并试图确定预后因素。
我们研究了我院共23例(14例男性和9例女性)接受静脉-动脉(VA)ECMO治疗的难治性感染性休克患者。分析了生存组和死亡组的临床参数,以及ECMO置入前后的实验室参数。
8例患者成功撤机,5例患者出院。生存组在ECMO置入前的脓毒症相关器官功能衰竭评估(SOFA)评分和休克至ECMO的间隔时间显著低于死亡组(分别为12.0对15.0,P = 0.007;23.5对42.2小时,P = 0.037)。在ECMO期间,生存组和死亡组在12小时(4对4,P = 0.033)、18小时(5对7,P = 0.016)和24小时(5对9,P = 0.043)时中心静脉血氧饱和度(ScvO)%处于正常范围的病例数有显著差异。在单因素逻辑回归分析中,ECMO期间12小时中心静脉血氧饱和度(ScvO)%正常的患者病例[比值比(OR)14.0,95%置信区间(CI):1.200 - 163.367,P = 0.035]与患者预后风险显著相关。
在成人难治性感染性休克患者中,ECMO期间12小时的ScvO%可能是患者预后的一个危险因素。